Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
PDX1258 | Luminespib | HSP90 | Misc | 0.01007 | -0.2899 | 0.6101 | 0.1943 | 5.0000 | 0.011049 | 0.99799 |
SUM1315MO2 | Luminespib | HSP90 | Misc | 0.0048627 | -0.0810 | 0.6112 | 0.1374 | 5.0000 | 0.0050309 | 0.99738 |
MDA-MB-361 | Buparlisib | pan PI3K | PI3K/mTOR | 0.21797 | -0.9584 | 0.6114 | 0.1763 | 0.9709 | 0.67584 | 0.99384 |
BT-549 | Luminespib | HSP90 | Misc | 0.0053858 | -0.1064 | 0.6123 | 0.1201 | 5.0000 | 0.0055748 | 0.99911 |
CAMA-1 | Abemaciclib | CDK4/6 | Cell cycle | 0.007859 | 0.2222 | 0.6130 | -0.0040 | 1.3608 | 0.0046978 | 0.97968 |
MCF 10A | Luminespib | HSP90 | Misc | 0.0076226 | -0.1717 | 0.6131 | 0.2622 | 3.1403 | 0.0083878 | 0.9999 |
HCC1954 | Volasertib | PLK | Cell cycle | 0.0065835 | -0.1540 | 0.6139 | 0.2792 | 3.4968 | 0.0071308 | 0.99812 |
MDA-MB-157 | Luminespib | HSP90 | Misc | 0.0041789 | -0.0490 | 0.6146 | 0.0676 | 4.3520 | 0.004258 | 0.99849 |
T47D | Everolimus | mTOR1 | PI3K/mTOR | -Inf | 0.2975 | 0.6157 | 0.0150 | 0.1000 | 5.9599e-07 | 0.77906 |
Hs 578T | Dinaciclib | pan CDK | Cell cycle | 0.0089363 | -0.2388 | 0.6160 | 0.2121 | 4.9934 | 0.0096082 | 0.99916 |
HCC1954 | Bleomycin | Radiation | Misc | 0.043847 | -0.0884 | 0.6166 | 0.2476 | 0.7506 | 0.05535 | 0.98102 |
HCC1500 | Taxol | Chemo | Chemotherapy | 0.0038131 | -0.0589 | 0.6182 | 0.1433 | 1.8138 | 0.0038924 | 0.96247 |
HCC1954 | Luminespib | HSP90 | Misc | 0.010331 | -0.3745 | 0.6188 | 0.2958 | 2.6936 | 0.012628 | 0.99618 |
HCC1395 | Luminespib | HSP90 | Misc | 0.0049953 | -0.1520 | 0.6195 | 0.0752 | 3.9193 | 0.0052747 | 0.99634 |
HCC1500 | AZD7762 | CHK1/2 | Cell cycle | 0.035943 | -0.2559 | 0.6218 | 0.1217 | 1.0434 | 0.037616 | 0.91391 |
Hs 578T | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0090588 | -0.0708 | 0.6226 | 0.1010 | 1.2366 | 0.0087974 | 0.98428 |
CAL-85-1 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0088347 | 0.0160 | 0.6258 | 0.0624 | 1.3592 | 0.0084516 | 0.99836 |
HCC1806 | Doxorubicin | Chemo | Chemotherapy | 0.015898 | -0.3241 | 0.6281 | 0.1971 | 1.0948 | 0.021206 | 0.97525 |
HCC38 | Luminespib | HSP90 | Misc | 0.0071367 | -0.2087 | 0.6295 | 0.1926 | 5.0000 | 0.0076296 | 0.99771 |
HCC1806 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.053677 | -0.0992 | 0.6297 | 0.1625 | 1.4311 | 0.062326 | 0.98998 |
HCC38 | Dinaciclib | pan CDK | Cell cycle | 0.012678 | -0.4422 | 0.6326 | 0.2241 | 4.1199 | 0.014763 | 0.99821 |
MDA-MB-436 | Luminespib | HSP90 | Misc | 0.0039107 | -0.0492 | 0.6326 | 0.0393 | 3.6046 | 0.004027 | 0.999 |
Hs 578T | Abemaciclib | CDK4/6 | Cell cycle | 0.077629 | -0.5825 | 0.6343 | 0.1966 | 0.4160 | 1.0889 | 0.95772 |
HCC1419 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0054867 | -0.3722 | 0.6345 | 0.0796 | 0.8272 | 0.0093689 | 0.98036 |
BT-549 | AZD7762 | CHK1/2 | Cell cycle | 0.066029 | -0.4824 | 0.6356 | 0.2312 | 1.6999 | 0.087287 | 0.97383 |